Option Care Health, Inc. (OPCH)
Option Care Health, Inc. operates in the Medical - Care Facilities industry of the Healthcare sector, headquartered in Bannockburn, IL, US. The stock last traded at $23.76, down 1.33% on the session, giving a market capitalisation of $3.56B. On trailing twelve-month figures it carries a trailing P/E of 17.86, a net margin of 3.7%. Its beta of 0.61 implies it has historically moved less than the broad market.
Option Care Health, Inc. delivers infusion services to patients in their homes and other non-hospital settings throughout the United States. The company offers a broad spectrum of specialized infusion treatments, including therapies for various infections, management of heart failure, and comprehensive nutritional support (both intravenous and tube feeding) for individuals with acute or chronic conditions such as stroke, cancer, and digestive illnesses. They also provide immunoglobulin infusions for immune system deficiencies and treatments targeting chronic inflammatory disorders like Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, and ulcerative colitis. Furthermore, Option Care Health assists in managing the progression of neurological conditions such as amyotrophic lateral sclerosis (ALS) and Duchenne muscular dystrophy. They also administer infusion therapies for bleeding disorders and provide crucial support for women experiencing high-risk pregnancies. Other specialized infusion services encompass pain relief, chemotherapy, and respiratory care. Complementing these medical offerings, the company provides professional nursing services. Option Care Health, Inc. maintains its primary corporate office in Bannockburn, Illinois.
Option Care Health, Inc. is most often compared with the following Healthcare names: